{"url_path":"/register/2026-05-13/2026-09543","section_key":"summary","section_title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Postmarketing Adverse Experience Reporting","topic":"register","document":{"doc_type":"Notice","doc_date":"2026-05-13","source_url":"https://www.federalregister.gov/documents/2026/05/13/2026-09543/agency-information-collection-activities-proposed-collection-comment-request-postmarketing-adverse","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Health and Human Services Department"},"word_count":119,"has_tables":false,"body_markdown":"# Agency Information Collection Activities; Proposed Collection; Comment Request; Postmarketing Adverse Experience Reporting\n\n**Type:** Notice\n**Published:** 2026-05-13\n**Citation:** 91 FR 27065\n**Agencies:** Health and Human Services Department, Food and Drug Administration\n**Source:** https://www.federalregister.gov/documents/2026/05/13/2026-09543/agency-information-collection-activities-proposed-collection-comment-request-postmarketing-adverse\n\n## Abstract\nThe Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on postmarketing reporting and recordkeeping of adverse experiences for drug and biological products."}